fiber supplement for glp-1 users SoWell digestion and heart health* GLP-1 users flock to the

A possible role of GLP-1 in the pathophysiology of early dumping syndrome

Liraglutide may be considered in people with BED primarily for weight loss, but current evidence does not support its use for binge remission

The bacteria do, by converting fiber into SCFAs

In a major clinical trial published in The New England Journal of Medicine , patients taking retatrutide lost an average of about 24% of their body weight after 48 weeks

In addition, several clinical trials have shown GLP-1 receptor agonists have demonstrated the capacity to reduce cardiovascular events and mitigate kidney disease

Benefits and risks of FDAapproved amyloidtargeting antibodies for treatment of early Alzheimer's disease: Navigating clinicianpatient engagement